PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReneuron Regulatory News (RENE)

  • This share is currently suspended. It was suspended at a price of 3.275

Share Price Information for Reneuron (RENE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.275
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3.275
RENE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TR-1: Notification of Major Interest in Shares

8 May 2012 10:52

RNS Number : 8692C
ReNeuron Group plc
08 May 2012
 



8 May 2012

AIM: RENE

 

ReNeuron Group plc

(the "Company")

 

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

 

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached:

RENEURON GROUP PLC

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

YES

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation:

Toscafund Asset Management LLP

4. Full name of shareholder(s)  (if different from 3.):

Tosca Mid Cap

DB Platinum Tosca Mid Cap Equity Fund

5. Date of the transaction and date onwhich the threshold is crossed orreached:

02/05/2012

6. Date on which issuer notified:

03/05/2012

7. Threshold(s) that is/are crossed orreached:

14%

 

8. Notified details:

A: Voting rights attached to shares

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

GB00B0DZML60

107,832,947

107,832,947

105,555,021

0

105,555,021

0

13.9357%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate

Exercise/Conversion Period

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date

Exercise/Conversion period

Number of voting rights instrument refers to

 

% of voting rights

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

105,555,021

13.9357%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable:

 

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

13. Additional information:

14. Contact name:

Robert Lord

15. Contact telephone number:

020 7845 6100

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLLIFEAEIITIIF
Date   Source Headline
12th Feb 20207:00 amRNSNotification of Major Holdings
7th Feb 20201:15 pmRNSNotification of Major Holdings
6th Feb 20209:51 amRNSNotification of Major Holdings
2nd Jan 20207:00 amRNSTotal Voting Rights
18th Dec 201912:10 pmRNSNotification of Major Holdings
16th Dec 20193:00 pmRNSNOTIFICATION OF MAJOR HOLDINGS
6th Dec 20197:00 amRNSInterim Results
18th Nov 20197:00 amRNSNotification of Interim Results
23rd Oct 20197:00 amRNSReNeuron's lead cell line shows further potential
17th Oct 20195:36 pmRNSNotification of Major Holdings
17th Oct 20193:21 pmRNSNotification of Major Holdings
14th Oct 20197:00 amRNSPositive clinical data presented at AAO meeting
2nd Oct 20194:40 pmRNSSecond Price Monitoring Extn
2nd Oct 20194:35 pmRNSPrice Monitoring Extension
2nd Oct 20197:00 amRNSClinical Update and Conference Presentations
12th Sep 201911:21 amRNSResult of AGM
10th Sep 20197:00 amRNSAGM Trading Update
2nd Sep 20197:00 amRNSBlock Listing Review and TVR
21st Aug 20197:00 amRNSAppointments to Scientific Advisory Board
14th Aug 20197:00 amRNSGrant-funded collaboration with exosome platform
2nd Aug 20194:00 pmRNSPosting of Annual Report and Notice of AGM
2nd Aug 20191:12 pmRNSNotification of Major Holdings
1st Aug 201911:50 amRNSTotal Voting Rights
17th Jul 20197:00 amRNSDirector/PDMR Interest in Shares & Share Options
16th Jul 20197:00 amRNSKey patent grants expand exosome IP portfolio
12th Jul 20197:00 amRNSSenior business development appointment
11th Jul 20197:00 amRNSPreliminary Results
8th Jul 20194:30 pmRNSNotification of Major Holdings
1st Jul 201911:00 amRNSPrice Monitoring Extension
1st Jul 20197:00 amRNSTotal Voting Rights
18th Jun 20194:01 pmRNSNotification of Major Holdings
18th Jun 20197:00 amRNSWebcast of Preliminary Results
14th Jun 201911:09 amRNSReNeuron wins Breakthrough of the Year Award
3rd Jun 20197:00 amRNSTotal Voting Rights
31st May 20197:00 amRNSJefferies 2019 Global Healthcare Conference
9th May 20195:05 pmRNSExercise of options, PDMR dealing and TVR
8th May 20197:00 amRNSYear-end update and results notification
2nd May 20193:43 pmRNSTotal Voting Rights
26th Apr 20194:40 pmRNSSecond Price Monitoring Extn
26th Apr 20194:35 pmRNSPrice Monitoring Extension
26th Apr 20197:00 amRNSClinical update and conference presentation
18th Apr 20193:40 pmRNSShare Purchases by Directors
12th Apr 20192:36 pmRNSExercise of Share Options and TVR
11th Apr 20194:31 pmRNSShare Purchases by Directors
10th Apr 20192:37 pmRNSDirector/PDMR Shares and Share Options
5th Apr 20197:00 amRNSReNeuron to present at UK investor conference
4th Apr 20197:00 amRNSClinical update and conference presentation
28th Mar 20192:05 pmRNSSecond Price Monitoring Extn
28th Mar 20192:00 pmRNSPrice Monitoring Extension
18th Mar 201912:00 pmRNSAlliance for Regenerative Medicine presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.